Generic model to unravel the deeper insights of viral infections: an empirical application of evolutionary graph coloring in computational network biology
Purpose Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring’s effectiveness in computational network biology, more precisely in ana...
Gespeichert in:
| Veröffentlicht in: | BMC bioinformatics Jg. 25; H. 1; S. 74 - 33 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
16.02.2024
BioMed Central Ltd Springer Nature B.V BMC |
| Schlagworte: | |
| ISSN: | 1471-2105, 1471-2105 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Purpose
Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring’s effectiveness in computational network biology, more precisely in analyzing protein–protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations.
Methods
To investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins.
Results
We first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences.
Conclusion
Our generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic. |
|---|---|
| AbstractList | Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring's effectiveness in computational network biology, more precisely in analyzing protein-protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations. To investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins. We first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences. Our generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic. Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring's effectiveness in computational network biology, more precisely in analyzing protein-protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations.PURPOSEGraph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring's effectiveness in computational network biology, more precisely in analyzing protein-protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations.To investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins.METHODSTo investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins.We first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences.RESULTSWe first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences.Our generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic.CONCLUSIONOur generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic. PurposeGraph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring’s effectiveness in computational network biology, more precisely in analyzing protein–protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations.MethodsTo investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins.ResultsWe first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences.ConclusionOur generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic. Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring's effectiveness in computational network biology, more precisely in analyzing protein-protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations. To investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins. We first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences. Our generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic. Abstract Purpose Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring’s effectiveness in computational network biology, more precisely in analyzing protein–protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations. Methods To investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins. Results We first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences. Conclusion Our generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic. Purpose Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring's effectiveness in computational network biology, more precisely in analyzing protein-protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations. Methods To investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins. Results We first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences. Conclusion Our generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic. Keywords: Differential evolution, Protein-protein interaction networks, Drug target, Generic model, Hub proteins, KEGG pathway, Respiratory disorder Purpose Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines, including biology. In this study, we demonstrate the graph coloring’s effectiveness in computational network biology, more precisely in analyzing protein–protein interaction (PPI) networks to gain insights about the viral infections and its consequences on human health. Accordingly, we propose a generic model that can highlight important hub proteins of virus-associated disease manifestations, changes in disease-associated biological pathways, potential drug targets and respective drugs. We test our model on SARS-CoV-2 infection, a highly transmissible virus responsible for the COVID-19 pandemic. The pandemic took significant human lives, causing severe respiratory illnesses and exhibiting various symptoms ranging from fever and cough to gastrointestinal, cardiac, renal, neurological, and other manifestations. Methods To investigate the underlying mechanisms of SARS-CoV-2 infection-induced dysregulation of human pathobiology, we construct a two-level PPI network and employed a differential evolution-based graph coloring (DEGCP) algorithm to identify critical hub proteins that might serve as potential targets for resolving the associated issues. Initially, we concentrate on the direct human interactors of SARS-CoV-2 proteins to construct the first-level PPI network and subsequently applied the DEGCP algorithm to identify essential hub proteins within this network. We then build a second-level PPI network by incorporating the next-level human interactors of the first-level hub proteins and use the DEGCP algorithm to predict the second level of hub proteins. Results We first identify the potential crucial hub proteins associated with SARS-CoV-2 infection at different levels. Through comprehensive analysis, we then investigate the cellular localization, interactions with other viral families, involvement in biological pathways and processes, functional attributes, gene regulation capabilities as transcription factors, and their associations with disease-associated symptoms of these identified hub proteins. Our findings highlight the significance of these hub proteins and their intricate connections with disease pathophysiology. Furthermore, we predict potential drug targets among the hub proteins and identify specific drugs that hold promise in preventing or treating SARS-CoV-2 infection and its consequences. Conclusion Our generic model demonstrates the effectiveness of DEGCP algorithm in analyzing biological PPI networks, provides valuable insights into disease biology, and offers a basis for developing novel therapeutic strategies for other viral infections that may cause future pandemic. |
| ArticleNumber | 74 |
| Audience | Academic |
| Author | De, Debashis Kole, Arnab Bag, Arup Kumar Pal, Anindya Jyoti |
| Author_xml | – sequence: 1 givenname: Arnab surname: Kole fullname: Kole, Arnab email: arnab.kole@tha.edu.in organization: Department of Computer Application, The Heritage Academy – sequence: 2 givenname: Arup Kumar surname: Bag fullname: Bag, Arup Kumar organization: Beckman Research Institute of City of Hope – sequence: 3 givenname: Anindya Jyoti surname: Pal fullname: Pal, Anindya Jyoti organization: University of Burdwan – sequence: 4 givenname: Debashis surname: De fullname: De, Debashis organization: Department of Computer Science and Engineering, Maulana Abul Kalam Azad University of Technology |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38365632$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks1u1DAUhSNURH_gBVggS2zKIsV2YsdhV1VQRqqExM_acpybjEsSBzsZ6KvwtNzMtJSpUJVFrq-_c-Jcn-PkYPADJMlLRs8YU_JtZFyJMqU8T6mQJU3pk-SI5QVLOaPi4J_6MDmO8ZpSVigqniWHmcqkkBk_Sn5fwgDBWdL7GjoyeTIPwWyWcg2kBhghEDdE166nSHxDNi6YDjsN2Mn5Ib4jZiDQjw5NcMOMY4fFsrXQsPHdvCxMuCFtMOOaWN_54IYWPbDux3na0qgdYPrpw3dSOUTam-fJ08Z0EV7cvk-Sbx_ef734mF59ulxdnF-lVig5pdZQllFeqYpltSoLI6EsjWS5KiyVzBRZBbywtkCkoIqrTBkmQPACjMxFkZ0kq51v7c21HoPr8bDaG6e3DR9abcLkbAc6lznOPGdC5mVe1dJQNG8yAU1JuapK9DrdeY3B_5ghTrp30ULXmQH8HDUvueK5oJwi-voBeu3ngHNYKCHxhihV91Rr8Ps4dj8FYxdTfV7gz3Be0sXr7D8UPjX0zmJqGof9PcGbPQEyE_yaWjPHqFdfPu-zr24POlc91H8ndBciBNQOsMHHGKDR1u0uFU_hOs2oXvKqd3nVmFe9zatevPkD6Z37o6JsJ4rjEiQI95N7RPUHvt_7GA |
| CitedBy_id | crossref_primary_10_1007_s42979_024_03480_2 |
| Cites_doi | 10.1097/CCE.0000000000000329 10.35940/ijitee.K1253.0981119 10.1016/j.compbiomed.2021.104591 10.1038/nprot.2008.211 10.1089/cmb.2019.0171 10.3389/fsysb.2022.815237 10.1098/rsob.210069 10.3390/microorganisms9061193 10.1038/s41401-020-00554-8 10.1164/rccm.201201-0077OC 10.1016/j.ijbiomac.2020.06.228 10.3389/fcvm.2020.623012 10.1016/j.csbj.2021.04.003 10.1093/nar/gkn923 10.1016/j.genrep.2020.100956 10.1038/ncb2329 10.1038/nrm3507 10.1016/j.asoc.2022.109510 10.1038/s12276-019-0299-y 10.3390/cimb45010023 10.1126/sciadv.abh3032 10.1038/s41421-020-0168-9 10.1038/s41598-021-95565-8 10.1165/rcmb.2008-0091TR 10.1111/andr.12837 10.1093/nar/gkj109 10.1073/pnas.1902310116 10.1016/j.matpr.2022.06.392 10.1136/ejhpharm-2020-002295 10.1038/s41598-022-08073-8 10.1016/j.redox.2022.102563 10.1038/s41586-020-2286-9 10.1002/pro.3978 10.3389/fendo.2017.00311 10.1021/acs.jproteome.0c00422 10.1177/0300060520958594 10.1186/s12859-020-03646-8 10.1186/1756-0381-4-10 10.1016/j.meegid.2022.105260 10.1049/iet-syb.2009.0038 10.1038/35052073 10.1038/s41467-022-28505-3 10.1101/2020.04.13.20063461 10.1016/j.cell.2017.02.004 10.1007/s00500-020-04815-w 10.1093/bib/bbaa425 10.3389/fimmu.2014.00113 10.1038/sj.embor.7400627 10.1021/acsomega.1c01375 10.1016/j.biopha.2021.112420 10.1038/s41598-021-99269-x 10.1016/j.nmni.2021.100853 10.1016/j.bbamcr.2022.119293 10.1242/jcs.133751 10.1038/s41392-022-00884-5 10.1155/2014/408514 10.1128/MCB.20.1.273-285.2000 10.1186/s12859-022-04910-9 10.1002/cpt.553 10.15252/emmm.201606261 10.1186/s12859-020-03770-5 10.1016/j.bj.2020.08.003 10.1080/22221751.2020.1799723 10.1016/j.devcel.2019.07.015 10.1016/j.jaut.2018.09.013 10.1038/s42256-022-00468-6 10.1016/S0014-5793(02)03270-2 10.1038/s41579-018-0118-9 10.4049/jimmunol.1200596 10.1186/s12931-018-0963-0 10.1016/j.phrs.2020.105030 10.3389/fbioe.2020.00034 10.1016/j.dnarep.2004.03.034 10.1038/sj.onc.1208615 10.1093/bib/bbaa173 10.1186/s12967-020-02480-z 10.3390/pathogens10121625 10.1016/j.cell.2020.08.025 10.1038/s41587-022-01474-0 10.1016/j.cor.2019.104850 10.3892/mmr.2016.5005 10.1016/j.ejor.2021.04.032 10.1007/s00500-019-04278-8 10.1155/2020/8827752 10.1038/s41579-020-00459-7 10.1038/s41421-020-0153-3 10.1016/j.dam.2021.05.021 10.1038/s41467-021-24482-1 10.1515/jbcpp-2020-0495 10.1016/j.cellsig.2021.110121 10.1007/s13278-014-0228-y 10.1038/s41421-021-00318-6 10.1038/s41597-020-00628-6 10.1080/07391102.2020.1852969 10.1016/j.cell.2018.01.029 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM ISR 3V. 7QO 7SC 7X7 7XB 88E 8AL 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU COVID DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ JQ2 K7- K9. L7M LK8 L~C L~D M0N M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 DOA |
| DOI | 10.1186/s12859-024-05690-0 |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed Gale In Context: Science ProQuest Central (Corporate) Biotechnology Research Abstracts Computer and Information Systems Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Computing Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection ProQuest One Coronavirus Research Database ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Collection (ProQuest) ProQuest Computer Science Collection Computer Science Database ProQuest Health & Medical Complete (Alumni) Advanced Technologies Database with Aerospace ProQuest Biological Science Collection Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Computing Database ProQuest Health & Medical Collection Medical Database Biological Science Database (ProQuest) Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Computer Science Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Computer Science Collection Computer and Information Systems Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Collection Technology Research Database Computer and Information Systems Abstracts – Academic ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Advanced Technologies Database with Aerospace ProQuest Computing ProQuest Central Basic ProQuest Computing (Alumni Edition) ProQuest SciTech Collection Computer and Information Systems Abstracts Professional Advanced Technologies & Aerospace Database ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1471-2105 |
| EndPage | 33 |
| ExternalDocumentID | oai_doaj_org_article_4641284156494bd6a03bef35ef9028b9 A782822900 38365632 10_1186_s12859_024_05690_0 |
| Genre | Journal Article |
| GeographicLocations | India |
| GeographicLocations_xml | – name: India |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAFWJ AAJSJ AAKPC AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADMLS ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ARAPS AZQEC BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 DWQXO E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO ICD IHR INH INR ISR ITC K6V K7- KQ8 LK8 M1P M48 M7P MK~ ML0 M~E O5R O5S OK1 OVT P2P P62 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XH6 XSB AAYXX AFFHD CITATION ALIPV NPM 3V. 7QO 7SC 7XB 8AL 8FD 8FK COVID FR3 JQ2 K9. L7M L~C L~D M0N P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 |
| ID | FETCH-LOGICAL-c586t-ca01302b8b13d897a6e99a61487c061a73be27cc72b87082838a15e527ea64573 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001163631200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2105 |
| IngestDate | Fri Oct 03 12:51:55 EDT 2025 Sun Nov 09 13:43:18 EST 2025 Tue Oct 07 05:11:41 EDT 2025 Tue Nov 11 11:11:18 EST 2025 Tue Nov 04 18:28:46 EST 2025 Wed Nov 26 11:25:23 EST 2025 Mon Jul 21 05:40:30 EDT 2025 Sat Nov 29 05:40:16 EST 2025 Tue Nov 18 22:35:09 EST 2025 Sat Sep 06 07:27:29 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Protein–protein interaction networks Hub proteins KEGG pathway Differential evolution Drug target Generic model Respiratory disorder |
| Language | English |
| License | 2024. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c586t-ca01302b8b13d897a6e99a61487c061a73be27cc72b87082838a15e527ea64573 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/4641284156494bd6a03bef35ef9028b9 |
| PMID | 38365632 |
| PQID | 2956836008 |
| PQPubID | 44065 |
| PageCount | 33 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_4641284156494bd6a03bef35ef9028b9 proquest_miscellaneous_2928245020 proquest_journals_2956836008 gale_infotracmisc_A782822900 gale_infotracacademiconefile_A782822900 gale_incontextgauss_ISR_A782822900 pubmed_primary_38365632 crossref_citationtrail_10_1186_s12859_024_05690_0 crossref_primary_10_1186_s12859_024_05690_0 springer_journals_10_1186_s12859_024_05690_0 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-02-16 |
| PublicationDateYYYYMMDD | 2024-02-16 |
| PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-16 day: 16 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC bioinformatics |
| PublicationTitleAbbrev | BMC Bioinformatics |
| PublicationTitleAlternate | BMC Bioinformatics |
| PublicationYear | 2024 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | M Karimi-Mamaghan (5690_CR14) 2022; 296 Y Wang (5690_CR78) 2014; 2014 M Baranwal (5690_CR27) 2022; 23 M Derakhshan (5690_CR97) 2020; 48 P Wu (5690_CR68) 2021; 12 MJ Tavassolifar (5690_CR94) 2023; 59 KB Karunakaran (5690_CR36) 2022; 2 N Kaneko (5690_CR70) 2020; 183 5690_CR4 SL Harris (5690_CR65) 2005; 24 A Roberts (5690_CR93) 2017; 101 DW Huang (5690_CR42) 2009; 37 C Stevens (5690_CR71) 2004; 3 R Nadeau (5690_CR10) 2020; 19 ML Ratliff (5690_CR66) 2014; 5 I di Bari (5690_CR77) 2021; 41 RA Rossi (5690_CR21) 2014; 4 JM Amrute (5690_CR87) 2022; 13 F Yang (5690_CR28) 2020; 21 G Taheri (5690_CR7) 2022; 128 W Wen (5690_CR86) 2020; 6 K Panhong (5690_CR38) 2022; 17 CH Serezani (5690_CR51) 2008; 39 D Narmadha (5690_CR25) 2019; 8 D Ginsberg (5690_CR72) 2002; 529 D Morichika (5690_CR82) 2019; 20 GN Sundar (5690_CR26) 2022; 133 H Mashayekhi-Sardoo (5690_CR60) 2021; 33 RA Saxton (5690_CR57) 2017; 168 M Farahani (5690_CR6) 2022; 145 N Han (5690_CR12) 2021; 7 Y Zhou (5690_CR32) 2023; 41 A Sharma (5690_CR85) 2021; 9 W Yan (5690_CR2) 2022; 7 AR Limkar (5690_CR76) 2021; 10 C Dupuis (5690_CR91) 2021; 3 LP Tavares (5690_CR52) 2020; 159 Y Li (5690_CR89) 2021; 7 A Bandyopadhyay (5690_CR23) 2020; 24 GP Dimri (5690_CR73) 2000; 20 B Hu (5690_CR3) 2021; 19 S Khor (5690_CR20) 2010; 4 P Luo (5690_CR96) 2021; 28 V Arige (5690_CR49) 2022; 1869 SA Lambert (5690_CR44) 2018; 172 S Appelberg (5690_CR58) 2020; 9 K Prasad (5690_CR9) 2020; 163 J Aguirre-Plans (5690_CR29) 2021; 22 P-D Denechaud (5690_CR74) 2017; 8 CM de Figueiredo (5690_CR16) 2022; 323 ZO Serebrovska (5690_CR62) 2020; 41 S Thadani (5690_CR19) 2022; 66 C Stark (5690_CR39) 2006; 34 F Seiler (5690_CR80) 2013; 190 R Oughtred (5690_CR40) 2021; 30 Y Niikura (5690_CR84) 2019; 50 DW Huang (5690_CR41) 2009; 4 A Haldar (5690_CR99) 2022; 99 R Feil (5690_CR54) 2006; 7 J Cui (5690_CR1) 2019; 17 B Xu (5690_CR95) 2021; 6 TH Cormen (5690_CR15) 2022 A Eijkelenboom (5690_CR47) 2013; 14 5690_CR45 Y Li (5690_CR11) 2022; 12 MJ Schuetz (5690_CR13) 2022; 4 AM Isidori (5690_CR55) 2021; 9 D Narmadha (5690_CR22) 2020; 24 C-K Chang (5690_CR33) 2021; 19 Z Nain (5690_CR75) 2021; 22 HM Al-Tamari (5690_CR79) 2018; 10 ÉP Zambalde (5690_CR59) 2022; 45 ML Ratliff (5690_CR67) 2019; 96 B Zhu (5690_CR69) 2019; 116 S Lopez-Leon (5690_CR46) 2021; 11 L Dey (5690_CR5) 2020; 43 X Yang (5690_CR43) 2021; 22 B Vastrad (5690_CR8) 2020; 21 GA Pavlopoulos (5690_CR18) 2011; 4 PS Cheema (5690_CR56) 2021; 11 MM Mihaylova (5690_CR64) 2011; 13 Y Zhou (5690_CR98) 2020; 6 SA Ochsner (5690_CR88) 2020; 7 M Koutrouli (5690_CR24) 2020; 8 K Yan (5690_CR50) 2016; 13 T Mostafaie (5690_CR17) 2020; 120 MG Gold (5690_CR53) 2013; 126 YY Sanders (5690_CR90) 2012; 186 JM Mir (5690_CR92) 2022; 40 SK Mondal (5690_CR35) 2021; 135 AR Sarohan (5690_CR81) 2021; 87 PK Jha (5690_CR83) 2021; 7 JW Lee (5690_CR61) 2019; 51 L Perrin-Cocon (5690_CR37) 2020; 18 T Mohanta (5690_CR48) 2020; 2020 L Dey (5690_CR30) 2020; 27 MP Mosharaf (5690_CR31) 2022; 12 Y Yarden (5690_CR63) 2001; 2 DE Gordon (5690_CR34) 2020; 583 |
| References_xml | – volume: 3 start-page: e0329 year: 2021 ident: 5690_CR91 publication-title: Crit Care Explor doi: 10.1097/CCE.0000000000000329 – volume: 8 start-page: 132 year: 2019 ident: 5690_CR25 publication-title: Int J Innov Technol Explor Eng doi: 10.35940/ijitee.K1253.0981119 – volume: 135 year: 2021 ident: 5690_CR35 publication-title: Comput Biol Med doi: 10.1016/j.compbiomed.2021.104591 – volume: 4 start-page: 44 year: 2009 ident: 5690_CR41 publication-title: Nat Protoc doi: 10.1038/nprot.2008.211 – volume: 27 start-page: 755 year: 2020 ident: 5690_CR30 publication-title: J Comput Biol doi: 10.1089/cmb.2019.0171 – volume: 2 start-page: 1 year: 2022 ident: 5690_CR36 publication-title: Front Syst Biol. doi: 10.3389/fsysb.2022.815237 – volume: 11 year: 2021 ident: 5690_CR56 publication-title: Open Biol doi: 10.1098/rsob.210069 – volume: 9 start-page: 1193 year: 2021 ident: 5690_CR85 publication-title: Microorganisms doi: 10.3390/microorganisms9061193 – volume: 41 start-page: 1539 year: 2020 ident: 5690_CR62 publication-title: Acta Pharmacol Sin doi: 10.1038/s41401-020-00554-8 – ident: 5690_CR45 – volume: 186 start-page: 525 year: 2012 ident: 5690_CR90 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201201-0077OC – volume: 163 start-page: 1 year: 2020 ident: 5690_CR9 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2020.06.228 – volume: 7 year: 2021 ident: 5690_CR83 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2020.623012 – volume: 19 start-page: 2246 year: 2021 ident: 5690_CR33 publication-title: Comput Struct Biotechnol J doi: 10.1016/j.csbj.2021.04.003 – volume: 37 start-page: 1 year: 2009 ident: 5690_CR42 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkn923 – volume: 21 year: 2020 ident: 5690_CR8 publication-title: Gene Reports doi: 10.1016/j.genrep.2020.100956 – volume: 13 start-page: 1016 year: 2011 ident: 5690_CR64 publication-title: Nat Cell Biol doi: 10.1038/ncb2329 – volume: 14 start-page: 83 year: 2013 ident: 5690_CR47 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm3507 – volume: 128 year: 2022 ident: 5690_CR7 publication-title: Appl Soft Comput doi: 10.1016/j.asoc.2022.109510 – volume: 51 start-page: 1 year: 2019 ident: 5690_CR61 publication-title: Exp Mol Med doi: 10.1038/s12276-019-0299-y – volume: 45 start-page: 327 year: 2022 ident: 5690_CR59 publication-title: Curr Issues Mol Biol doi: 10.3390/cimb45010023 – volume: 7 start-page: eabh3032 year: 2021 ident: 5690_CR12 publication-title: Sci Adv doi: 10.1126/sciadv.abh3032 – volume: 6 start-page: 31 year: 2020 ident: 5690_CR86 publication-title: Cell Discov doi: 10.1038/s41421-020-0168-9 – volume: 133 start-page: 31 year: 2022 ident: 5690_CR26 publication-title: CMES Comput Model Eng Sci – volume: 11 start-page: 16144 year: 2021 ident: 5690_CR46 publication-title: Sci Rep doi: 10.1038/s41598-021-95565-8 – volume: 39 start-page: 127 year: 2008 ident: 5690_CR51 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2008-0091TR – volume: 9 start-page: 33 year: 2021 ident: 5690_CR55 publication-title: Andrology doi: 10.1111/andr.12837 – volume: 34 start-page: D535 year: 2006 ident: 5690_CR39 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkj109 – volume: 116 start-page: 11888 year: 2019 ident: 5690_CR69 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1902310116 – volume: 66 start-page: 3498 year: 2022 ident: 5690_CR19 publication-title: Mater Today Proc doi: 10.1016/j.matpr.2022.06.392 – volume: 28 start-page: e1 year: 2021 ident: 5690_CR96 publication-title: Eur J Hosp Pharm doi: 10.1136/ejhpharm-2020-002295 – volume: 12 start-page: 4279 year: 2022 ident: 5690_CR31 publication-title: Sci Rep doi: 10.1038/s41598-022-08073-8 – volume: 59 year: 2023 ident: 5690_CR94 publication-title: Redox Biol doi: 10.1016/j.redox.2022.102563 – volume: 583 start-page: 459 year: 2020 ident: 5690_CR34 publication-title: Nature doi: 10.1038/s41586-020-2286-9 – volume: 30 start-page: 187 year: 2021 ident: 5690_CR40 publication-title: Protein Sci doi: 10.1002/pro.3978 – volume: 8 start-page: 311 year: 2017 ident: 5690_CR74 publication-title: Front Endocrinol doi: 10.3389/fendo.2017.00311 – volume: 19 start-page: 4553 year: 2020 ident: 5690_CR10 publication-title: J Proteome Res doi: 10.1021/acs.jproteome.0c00422 – volume: 48 start-page: 030006052095859 year: 2020 ident: 5690_CR97 publication-title: J Int Med Res doi: 10.1177/0300060520958594 – volume: 21 start-page: 1 year: 2020 ident: 5690_CR28 publication-title: BMC Bioinform doi: 10.1186/s12859-020-03646-8 – volume: 4 start-page: 1 year: 2011 ident: 5690_CR18 publication-title: BioData Min doi: 10.1186/1756-0381-4-10 – volume: 99 year: 2022 ident: 5690_CR99 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2022.105260 – volume: 4 start-page: 185 year: 2010 ident: 5690_CR20 publication-title: IET Syst Biol doi: 10.1049/iet-syb.2009.0038 – volume: 2 start-page: 127 year: 2001 ident: 5690_CR63 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/35052073 – volume: 13 start-page: 882 year: 2022 ident: 5690_CR87 publication-title: Nat Commun doi: 10.1038/s41467-022-28505-3 – ident: 5690_CR4 doi: 10.1101/2020.04.13.20063461 – volume: 168 start-page: 960 year: 2017 ident: 5690_CR57 publication-title: Cell doi: 10.1016/j.cell.2017.02.004 – volume: 24 start-page: 14707 year: 2020 ident: 5690_CR22 publication-title: Soft Comput doi: 10.1007/s00500-020-04815-w – volume: 22 start-page: 832 year: 2021 ident: 5690_CR43 publication-title: Brief Bioinform doi: 10.1093/bib/bbaa425 – volume: 5 start-page: 113 year: 2014 ident: 5690_CR66 publication-title: Front Immunol doi: 10.3389/fimmu.2014.00113 – volume: 7 start-page: 149 year: 2006 ident: 5690_CR54 publication-title: EMBO Reports doi: 10.1038/sj.embor.7400627 – volume: 6 start-page: 16826 year: 2021 ident: 5690_CR95 publication-title: ACS Omega doi: 10.1021/acsomega.1c01375 – volume: 145 year: 2022 ident: 5690_CR6 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2021.112420 – volume: 12 start-page: 1 year: 2022 ident: 5690_CR11 publication-title: Sci Rep doi: 10.1038/s41598-021-99269-x – volume: 41 year: 2021 ident: 5690_CR77 publication-title: New Microbes New infect doi: 10.1016/j.nmni.2021.100853 – volume: 1869 year: 2022 ident: 5690_CR49 publication-title: Biochim Biophys Acta (BBA) Mol Cell Res doi: 10.1016/j.bbamcr.2022.119293 – volume: 126 start-page: 4537 year: 2013 ident: 5690_CR53 publication-title: J Cell Sci doi: 10.1242/jcs.133751 – volume: 7 start-page: 26 year: 2022 ident: 5690_CR2 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-022-00884-5 – volume: 2014 start-page: 1 year: 2014 ident: 5690_CR78 publication-title: BioMed Res Int. doi: 10.1155/2014/408514 – volume: 20 start-page: 273 year: 2000 ident: 5690_CR73 publication-title: Mol Cell Biol doi: 10.1128/MCB.20.1.273-285.2000 – volume: 23 start-page: 370 year: 2022 ident: 5690_CR27 publication-title: BMC Bioinform doi: 10.1186/s12859-022-04910-9 – volume: 101 start-page: 89 year: 2017 ident: 5690_CR93 publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.553 – volume: 10 start-page: 276 year: 2018 ident: 5690_CR79 publication-title: EMBO Mol Med doi: 10.15252/emmm.201606261 – volume: 22 start-page: 1 year: 2021 ident: 5690_CR29 publication-title: BMC Bioinform doi: 10.1186/s12859-020-03770-5 – volume: 43 start-page: 438 year: 2020 ident: 5690_CR5 publication-title: Biomed J doi: 10.1016/j.bj.2020.08.003 – volume: 9 start-page: 1748 year: 2020 ident: 5690_CR58 publication-title: Emerg Microbes infect doi: 10.1080/22221751.2020.1799723 – volume: 50 start-page: 683 year: 2019 ident: 5690_CR84 publication-title: Dev Cell doi: 10.1016/j.devcel.2019.07.015 – volume: 96 start-page: 158 year: 2019 ident: 5690_CR67 publication-title: J Autoimmun doi: 10.1016/j.jaut.2018.09.013 – volume: 4 start-page: 367 year: 2022 ident: 5690_CR13 publication-title: Nat Mach Intell doi: 10.1038/s42256-022-00468-6 – volume: 529 start-page: 122 year: 2002 ident: 5690_CR72 publication-title: FEBS Lett doi: 10.1016/S0014-5793(02)03270-2 – volume: 17 start-page: 181 year: 2019 ident: 5690_CR1 publication-title: Nat Rev Microbiol doi: 10.1038/s41579-018-0118-9 – volume: 17 start-page: 331 year: 2022 ident: 5690_CR38 publication-title: Adv Dyn Syst Appl (ADSA) – volume: 190 start-page: 1603 year: 2013 ident: 5690_CR80 publication-title: J Immunol doi: 10.4049/jimmunol.1200596 – volume: 20 start-page: 1 year: 2019 ident: 5690_CR82 publication-title: Respir Res doi: 10.1186/s12931-018-0963-0 – volume: 159 year: 2020 ident: 5690_CR52 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2020.105030 – volume: 8 start-page: 34 year: 2020 ident: 5690_CR24 publication-title: Front Bioeng Biotechnol doi: 10.3389/fbioe.2020.00034 – volume: 3 start-page: 1071 year: 2004 ident: 5690_CR71 publication-title: DNA Repair doi: 10.1016/j.dnarep.2004.03.034 – volume: 24 start-page: 2899 year: 2005 ident: 5690_CR65 publication-title: Oncogene doi: 10.1038/sj.onc.1208615 – volume: 22 start-page: 1175 year: 2021 ident: 5690_CR75 publication-title: Brief Bioinform doi: 10.1093/bib/bbaa173 – volume: 18 start-page: 1 year: 2020 ident: 5690_CR37 publication-title: J Transl Med doi: 10.1186/s12967-020-02480-z – volume: 10 start-page: 1625 year: 2021 ident: 5690_CR76 publication-title: Pathogens doi: 10.3390/pathogens10121625 – volume: 183 start-page: 143 year: 2020 ident: 5690_CR70 publication-title: Cell doi: 10.1016/j.cell.2020.08.025 – volume: 41 start-page: 128 issue: 1 year: 2023 ident: 5690_CR32 publication-title: Nat Biotechnol. doi: 10.1038/s41587-022-01474-0 – volume: 120 year: 2020 ident: 5690_CR17 publication-title: Comput Oper Res doi: 10.1016/j.cor.2019.104850 – volume: 13 start-page: 3715 year: 2016 ident: 5690_CR50 publication-title: Mol Med Rep doi: 10.3892/mmr.2016.5005 – volume: 296 start-page: 393 year: 2022 ident: 5690_CR14 publication-title: Eur J Oper Res doi: 10.1016/j.ejor.2021.04.032 – volume-title: Introduction to algorithms year: 2022 ident: 5690_CR15 – volume: 24 start-page: 603 year: 2020 ident: 5690_CR23 publication-title: Soft Comput doi: 10.1007/s00500-019-04278-8 – volume: 2020 start-page: 1 year: 2020 ident: 5690_CR48 publication-title: BioMed Res Int. doi: 10.1155/2020/8827752 – volume: 19 start-page: 141 year: 2021 ident: 5690_CR3 publication-title: Nat Rev Microbiol doi: 10.1038/s41579-020-00459-7 – volume: 6 start-page: 14 year: 2020 ident: 5690_CR98 publication-title: Cell Discov doi: 10.1038/s41421-020-0153-3 – volume: 323 start-page: 184 year: 2022 ident: 5690_CR16 publication-title: Discrete Appl Math doi: 10.1016/j.dam.2021.05.021 – volume: 12 start-page: 4543 year: 2021 ident: 5690_CR68 publication-title: Nat Commun doi: 10.1038/s41467-021-24482-1 – volume: 33 start-page: 17 year: 2021 ident: 5690_CR60 publication-title: J Basic Clin Physiol Pharmacol doi: 10.1515/jbcpp-2020-0495 – volume: 87 year: 2021 ident: 5690_CR81 publication-title: Cell Signal doi: 10.1016/j.cellsig.2021.110121 – volume: 4 start-page: 1 year: 2014 ident: 5690_CR21 publication-title: Soc Netw Anal Min doi: 10.1007/s13278-014-0228-y – volume: 7 start-page: 76 year: 2021 ident: 5690_CR89 publication-title: Cell Discov doi: 10.1038/s41421-021-00318-6 – volume: 7 start-page: 314 year: 2020 ident: 5690_CR88 publication-title: Sci Data doi: 10.1038/s41597-020-00628-6 – volume: 40 start-page: 4285 year: 2022 ident: 5690_CR92 publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2020.1852969 – volume: 172 start-page: 650 year: 2018 ident: 5690_CR44 publication-title: Cell doi: 10.1016/j.cell.2018.01.029 |
| SSID | ssj0017805 |
| Score | 2.4360788 |
| Snippet | Purpose
Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific... Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines,... Purpose Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific... PurposeGraph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific disciplines,... Abstract Purpose Graph coloring approach has emerged as a valuable problem-solving tool for both theoretical and practical aspects across various scientific... |
| SourceID | doaj proquest gale pubmed crossref springer |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 74 |
| SubjectTerms | Algorithms Bioinformatics Biological activity Biology Biomarkers Biomedical and Life Sciences Computational biology Computational Biology/Bioinformatics Computational neuroscience Computer Appl. in Life Sciences Cough COVID-19 Differential evolution Disease transmission DNA binding proteins Drug target Drugs Effectiveness Empirical analysis Epidemics Evolutionary computation Gene regulation Generic model Genetic transcription Graph coloring Graph theory Health aspects Hub proteins Identification India Infection Infections KEGG pathway Life Sciences Localization Medical research Medicine, Experimental Microarrays Neural networks Optimization Pandemics Pathophysiology Problem solving Protein-protein interactions Proteins Protein–protein interaction networks Respiratory diseases Severe acute respiratory syndrome coronavirus 2 Signs and symptoms Therapeutic targets Transcription factors Viral diseases Viral infections Virus research Viruses |
| SummonAdditionalLinks | – databaseName: Biological Science Database (ProQuest) dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggNQL70KgIIOQOIDVOI5jhwsqiAokVFU8pN4sx5mUldpkSXYr9a_wa_E4zrYLohduUTJ2bM94xvaMvyHkhW6g0rnzwisrxXKec1Y1omGpsiBtkzqoA6c_q_19fXhYHsQDtyGGVU46MSjqunN4Rr6T4b024c2zfjv_yTBrFHpXYwqNq-QaoiRkIXTvYOVFQLz-6aKMLnYGjmhtzFsl5s1-mbJ0zRgFzP6_NfMF0_SHrzSYoL1b_9v42-RmXHzS3VFa7pAr0N4lN8Z0lGf3yK-AQT1zNKTHoYuOLlvMTuQffwCtAebQ01k74H5-oF1DMUD4mE7xXO3whtqWwsl8FnBH6AXnOFLDaRRz25_RAJRNETIb--rroC7kl4hnk7Qdw9NpBIm6T77vffj2_iOLuRuYk7pYMGeDS7TSFRe1LpUtoCwtoo4q55cQVokKMuWc8iQKYfSEtlyCzBTYIpdKbJGNtmvhIaFKeU3h_MKoBplzLmwNAlxZFbwWDqxKCJ-YaFwENsf8GscmbHB0YUbGG894Exhv0oS8WpWZj7Ael1K_Q9lYUSIkd3jR9UcmznCTFznaegTfKfOqLmzqu9gICQ0C5FRlQp6jZBkE3WgxqufILofBfPr6xez6ZVoA3vd_ehmJms73wdl4ScKPBOJ0rVFur1F6reDWP0-SaKJWGsy5GCbk2eozlsRIuxa6JdL4GnLpdxEJeTAK_qrfwheWhcgS8nqaCeeV_3v4Hl3elsdkMwtzMmO82CYbi34JT8h1d7qYDf3TMKN_A44bUdQ priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9UwDI7QAIkX7pfCQAEh8QDV2qZtUt4GYgIJTWgDtLcoTd1xpJEetedM2l_h12KnadnhJsFb1Tpp4jq2UzufGXuqWqhVblF4i1rGeZqncd2KNk6kgcK0iYXGf-n3cn9fHR1VH8KhsGHKdp9Ckl5T-2Wtyp0hJay1GG1KjEa7SmLcqF9Ec6eoYMPB4ec5dkAo_dPxmN-22zBBHqn_V318ziD9FCH1hmfv2v8N-Tq7GhxNvjtKxg12AdxNdnksPXl2i33zeNMLy30pHL7q-NpRJSK8_AK8AVhCzxduoL37wLuWUzLwCZ9yt9zwkhvH4ety4TFG-LlAOFHDaRBp059xD4rNCR6bRo99cOtrSYT_kNyNqeg8AELdZp_23nx8_TYOdRpiW6hyFVvjw5-1qlPRqEqaEqrKEMKotOguGClqyKS1EkkkQeYJZdICikyCKfNCijtsy3UO7jEuJWoFi05QA0WepsI0IMBWdZk2woKREUunT6dtADGnWhon2m9mVKlHnmvkufY810nEns9tliOEx1-pX5FEzJQEv-1vdP2xDqtZ52VOdp2Adqq8bkqT4BRbUUBLYDh1FbEnJE-aADYcZfAcm_Uw6HeHB3oXXTIPso9vehaI2g7nYE04EIGcIEyuDcrtDUrUAHbz8SS2OmigQWd0DlSgO6si9nh-TC0pq85BtyYa7CEvcMcQsbujuM_zFti4KEUWsReTbP_o_M_su_9v5A_YlcwvjyxOy222terX8JBdsqerxdA_8uv6O1qAR-0 priority: 102 providerName: Springer Nature |
| Title | Generic model to unravel the deeper insights of viral infections: an empirical application of evolutionary graph coloring in computational network biology |
| URI | https://link.springer.com/article/10.1186/s12859-024-05690-0 https://www.ncbi.nlm.nih.gov/pubmed/38365632 https://www.proquest.com/docview/2956836008 https://www.proquest.com/docview/2928245020 https://doaj.org/article/4641284156494bd6a03bef35ef9028b9 |
| Volume | 25 |
| WOSCitedRecordID | wos001163631200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: RBZ dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center) customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: M~E dateStart: 20000101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: P5Z dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database (ProQuest) customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: M7P dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Computer Science Database customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: K7- dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/compscijour providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: RSV dateStart: 20001201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELdggMQL4u8IjMogJB7AWhLHccLbhjYxAVXUASq8WI7jQKWRVE07aV-FT8ud45QWBLzwYiX12Unuzr5zff4dIU-z2pZZYkB5RSlZEiURK2tes1BqK3QdGls5Sb-V43E2nebFRqovjAnr4YF7xu0naYJTKGKa5ElZpTrkpa25sDXijpTu6F4o82Ex5fcPEKl_OCKTpftdhDhtDOwRA4OfhyzcMkMOrf_3OXnDKP2yS-qMz_FNcsN7jfSgf9tb5JJtbpNrfR7JizvkuwOPnhnq8trQZUtXDaYVgsuvllbWzu2CzpoOF-IdbWuKkb1ndAjEarqXVDfUfpvPHGAI3djVRmp77vVTLy6oQ7imiHWNrwp9UOMSQ_g_FWnTx5VTj-50l3w4Pnr_6jXzSReYEVm6ZEa7vcwyKyNeZbnUqc1zjXCh0oDt1xLYH0tjJJBIxL_jmY6EFbG0Ok2E5PfITtM29j6hUsIQN-DRVFYkUcR1Zbk1eZlGFTdWy4BEgwyU8YjkmBjjTLmVSZaqXm4K5Kac3FQYkOfrNvMej-Ov1Ico2jUlYmm7H0DDlNcw9S8NC8gTVAyFaBkNhuN80auuUyenE3UA_pVDzIcnPfNEdQvfYLQ_3QCcQICtLcq9LUoYzma7etA_5aeTTsV4qJODb5oF5PG6GltiiFxj2xXSQA-JAPc_ILu93q6_m0NjkfI4IC8GRf7Z-Z_Z9-B_sO8huR67gRezKN0jO8vFyj4iV835ctYtRuSynEpXZiNy5fBoXExGbihD-UayEcbiFlAW4jPUFyfvik9wNzn9-APVm0u1 |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGAMEL90thgEEgHsBaEidxgoTQuEyrWioEQ9qbcZyTUWkkpWmH-lf4EfxGznGSbgWxtz3wVjXHbu2ci-1z_H2MPU4KyJLQovJGmRKhH_oiK2QhPGUgMoVnIXdveqhGo2RvL_2wxn51d2GorLLzic5R55WlM_LNgO61SQzPyavJd0GsUZRd7Sg0GrUYwOIHbtnql_23-H6fBMH2u903O6JlFRA2SuKZsMYl67Ik82WepMrEkKaG8DCVxeBmlMwgUNYqFFEE8CYT40cQBQpMHEZKYr9n2NlQJorsaqDEMmtB_ADdxZwk3qx9QocTGAUFLjNST3grwc9xBPwdCY6Fwj9ysy7kbV_-3ybrCrvULq75VmMNV9kalNfY-YZuc3Gd_XQY22PLHf0Pn1V8XhL7En78CjwHmMCUj8uazitqXhWcCqAPeFevVtYvuCk5fJuMHa4KP5b8J2k4bM3YTBfcAYFzggSnucU-uHX8Ge3ZKy-b8nvegmDdYJ9PZWJusvWyKuE240qhJ7S48MshCn1fmhwk2DSL_VxaMKrH_E5ptG2B24k_5EC7DVwS60bRNCqadoqmvR57tmwzaWBLTpR-Tbq4lCTIcfdFNd3XrQfTYRzSWobAhdIwy2Pj4RALGUFBAEBZ2mOPSJM1gYqUVLW0b-Z1rfufPuotXIY6YgH8paetUFHhGKxpL4HgTBAO2Yrkxookej27-rjTfN163VofqX2PPVw-ppZUSVhCNScZ7CGMcJfUY7caQ1uOW2LjKJZBjz3vLO-o839P352T_8sDdmFn9_1QD_ujwV12MXD-IBB-vMHWZ9M53GPn7OFsXE_vO2_C2ZfTtsjfyF6rfA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zj9QwDI7QcogX7qOwQEBIPEC1bdM2LW_LMWLFarRiAe1blKbuMtKSjtrOSvtX-LXY6cEMl4R4q6ZO2rhObI_tz4w9zSoostig8CaF9OMwDv2iEpUfSA2JrgIDpfvS-3I-z46O8oO1Kn6X7T6GJPuaBkJpst3Osqz6LZ6lO21IuGs-6hcfFXge-Oi0n48pkZ789cPPUxyBEPvHUpnfjttQRw61_9ezeU05_RQtdUpodvX_X_8auzIYoHy3l5jr7BzYG-xi35Ly7Cb75nCoF4a7Fjm8q_nKUocivPwCvARYQsMXtiWfvuV1xSlJ-ISPOV22fcm15fB1uXDYI3wtQE7UcDqIum7OuAPL5gSbTSvBObhxPSaG_ye57VPU-QAUdYt9mr39-PqdP_Rv8E2SpZ1vtAuLFlkRijLLpU4hzzUhj0qDZoSWooBIGiORRBKUnsh0mEASSdBpnEhxm23Z2sJdxqXE08KgcVRCEoeh0CUIMHmRhqUwoKXHwvEzKjOAm1OPjRPlnJwsVT3PFfJcOZ6rwGPPpzHLHtrjr9SvSDomSoLldj_UzbEadrmK05j0PQHw5HFRpjrAJVYigYpAcorcY09IthQBb1jK7DnWq7ZVe4cf1C6aag58H5_0bCCqalyD0UOhBHKCsLo2KLc3KPFkMJu3RxFWw8nUqojqQwWauZnHHk-3aSRl21moV0SDM8QJehIeu9OL_rRugYOTVEQeezHK-Y_J_8y-e_9G_ohdOngzU_t78_f32eXI7ZTID9NtttU1K3jALpjTbtE2D912_w47W1O1 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Generic+model+to+unravel+the+deeper+insights+of+viral+infections%3A+an+empirical+application+of+evolutionary+graph+coloring+in+computational+network+biology&rft.jtitle=BMC+bioinformatics&rft.au=Arnab+Kole&rft.au=Arup+Kumar+Bag&rft.au=Anindya+Jyoti+Pal&rft.au=Debashis+De&rft.date=2024-02-16&rft.pub=BMC&rft.eissn=1471-2105&rft.volume=25&rft.issue=1&rft.spage=1&rft.epage=33&rft_id=info:doi/10.1186%2Fs12859-024-05690-0&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_4641284156494bd6a03bef35ef9028b9 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2105&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2105&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2105&client=summon |